- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (334)
- Timeline of Article Publication (6)
- Authors Evaluation (8)
- Article Quality Tracking (0)
- Reference Citation Analysis (5)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6531)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2023 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Petagine L, Zariwala MG, Patel VB. Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments. World J Gastroenterol 2023; 29(32): 4831-4850 [PMID: 37701135 DOI: 10.3748/wjg.v29.i32.4831] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i32/4831.htm |
| Number | Citing Articles |
| 1 |
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv. Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1336493
|
| 2 |
Ahmed M. Samy, Mohamed A. Kandeil, Dina Sabry, A.A. Abdel-Ghany, Mohamed O. Mahmoud. From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences. Heliyon 2024; 10(9): e30387 doi: 10.1016/j.heliyon.2024.e30387
|
| 3 |
Lakshmi Arivazhagan, Sofie Delbare, Robin A. Wilson, Michaele B. Manigrasso, Boyan Zhou, Henry H. Ruiz, Kaamashri Mangar, Ryoko Higa, Emily Brown, Huilin Li, Michael J. Garabedian, Ravichandran Ramasamy, Kathryn J. Moore, Edward A. Fisher, Neil D. Theise, Ann Marie Schmidt. Sex differences in Murine MASH evoked by a Fructose-Palmitate-Cholesterol-Enriched Diet. JHEP Reports 2024; : 101222 doi: 10.1016/j.jhepr.2024.101222
|
| 4 |
U. Arshad, J.E.P. Santos. Graduate Student Literature Review: Exploring choline's important roles as a nutrient for transition dairy cows. Journal of Dairy Science 2024; 107(7): 4357 doi: 10.3168/jds.2023-24050
|
| 5 |
Shao-Hong Tao, Yu-Qing Lei, Yi-Mei Tan, Yu-Bo Yang, Wei-Ning Xie. Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1476419
|
| 6 |
Asahiro Morishita, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Joji Tani, Hideki Kobara, Masafumi Ono, Takashi Himoto, Tsutomu Masaki. MicroRNAs and Nonalcoholic Steatohepatitis: A Review. International Journal of Molecular Sciences 2023; 24(19): 14482 doi: 10.3390/ijms241914482
|
| 7 |
Isabella D. Cooper, Yvoni Kyriakidou, Kurtis Edwards, Lucy Petagine, Thomas N. Seyfried, Tomas Duraj, Adrian Soto-Mota, Andrew Scarborough, Sandra L. Jacome, Kenneth Brookler, Valentina Borgognoni, Vanusa Novaes, Rima Al-Faour, Bradley T. Elliott. Ketosis Suppression and Ageing (KetoSAge): The Effects of Suppressing Ketosis in Long Term Keto-Adapted Non-Athletic Females. International Journal of Molecular Sciences 2023; 24(21): 15621 doi: 10.3390/ijms242115621
|
| 8 |
Grigorios Papadopoulos, Eirini Giannousi, Aikaterini P. Avdi, Rallia-Iliana Velliou, Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou. Τ cell-mediated adaptive immunity in the transition from metabolic dysfunction-associated steatohepatitis to hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1343806
|
| 9 |
Karolina Dereń, Joanna Kapusta-Duch, Teresa Leszczyńska, Barbara Borczak, Marta Kotuła. Pro-Health Potential of Selected Uncommon Oilseed Plants. Applied Sciences 2024; 14(19): 8843 doi: 10.3390/app14198843
|
| 10 |
Rhys W. Niedecker, Joseph A. Delaney, Margaret F. Doyle, Andrew D. Sparks, Colleen M. Sitlani, Petra Buzkova, Irfan Zeb, Russell P. Tracy, Bruce M. Psaty, Matthew J. Budoff, Nels C. Olson. Investigating peripheral blood monocyte and T-cell subsets as non-invasive biomarkers for asymptomatic hepatic steatosis: results from the Multi-Ethnic Study of Atherosclerosis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1243526
|
| 11 |
Zhenguo Luo, Shu Yan, Yu Chao, Ming Shen. Unveiling the mitophagy puzzle in non-alcoholic fatty liver disease (NAFLD): Six hub genes for early diagnosis and immune modulatory roles. Heliyon 2024; 10(7): e28935 doi: 10.1016/j.heliyon.2024.e28935
|
| 12 |
Isabella D. Cooper, Yvoni Kyriakidou, Lucy Petagine, Kurtis Edwards, Adrian Soto-Mota, Kenneth Brookler, Bradley T. Elliott. Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females. Biomedicines 2024; 12(7): 1553 doi: 10.3390/biomedicines12071553
|
| 13 |
ChongLi Xu, Fengyang Fu, Yuhan She, ChongBo Xu. NPC1L1 Plays a Novel Role in Nonalcoholic Fatty Liver Disease. ACS Omega 2023; 8(51): 48586 doi: 10.1021/acsomega.3c07337
|
| 14 |
Winston T. Stauffer, Asha Z. Goodman, Philippe A. Gallay. Cyclophilin inhibition as a strategy for the treatment of human disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1417945
|